Many believe Stage 3 adjudication via ISCAS is prohibitively expensive – but the facts speak for themselves.
ISCAS, owned by charity CEDR, is a not-for-profit adjudicator dedicated solely to private healthcare, making it the most experienced, transparent choice in the market.
According to ISCAS’s latest data (2024–2025), the average adjudication cost was £1,590, with goodwill awards averaging £843 – trending downward year-on-year. The trend is clear: ISCAS remains competitive – not exorbitant.
Contrast this with anecdotal numbers suggesting higher costs, and it’s clear that ISCAS offers value grounded in sector expertise, impartiality, and reputation.
For providers and patients alike, opting for independent adjudication isn’t just a procedural step, it’s a statement of fairness, integrity, and trust.
Discover the truth – download the latest ISCAS report.
Ready to demonstrate fairness and transparency? Contact us to learn more about independent adjudication through ISCAS.”